Clinical Trial Update: LUX-Dx Insertable Cardiac Monitor Remote Programming and Performance Study

View source ↗

Summary

Completed clinical trial update for the LUX-Dx insertable cardiac monitor focusing on remote programming and performance. Results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Cryptogenic Stroke
• Syncope

Snippet

Sponsor: Boston Scientific Corporation | Conditions: Atrial Fibrillation, Syncope | Status: COMPLETED | Results posted: 2024-11-25